The Valley Desk

NCT00500539 · Interventional trial

Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.

Overall registry status Completed

Phase 3

Conditions Asthma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov